Chemomab Therapeutics Ltd
CMMB1.010USD
-0.020-1.95%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
19.05MMarket Cap
LossP/E TTM
Chemomab Therapeutics Ltd
1.010
-0.020-1.95%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Operating expenses
-13.86%3.49M
-16.50%3.21M
-15.04%3.71M
-54.02%3.77M
-55.27%4.05M
-55.47%3.85M
-47.49%4.37M
31.04%8.20M
70.09%9.05M
72.01%8.64M
187.69%8.32M
127.17%6.25M
213.13%5.32M
125.49%5.02M
136.00%2.89M
150.05%2.75M
-0.29%1.70M
-3.72%2.23M
-83.15%1.23M
-75.74%1.10M
-68.60%1.70M
--2.31M
--7.27M
--4.54M
--5.43M
R&D expenses
-19.89%2.49M
-22.15%2.41M
-16.02%2.84M
-41.67%2.93M
-54.81%3.11M
-47.46%3.10M
-37.73%3.38M
72.27%5.02M
150.89%6.89M
147.38%5.89M
264.69%5.42M
122.95%2.91M
137.25%2.75M
1269.54%2.38M
44.23%1.49M
54.31%1.31M
-25.45%1.16M
-83.06%174.00K
-81.47%1.03M
-67.12%847.00K
-62.47%1.55M
--1.03M
--5.56M
--2.58M
--4.13M
Depreciation, depletion, and amortization
----
----
----
----
----
14.29%16.00K
11.76%19.00K
14.29%16.00K
23.08%16.00K
27.27%14.00K
88.89%17.00K
100.00%14.00K
85.71%13.00K
266.67%11.00K
12.50%9.00K
40.00%7.00K
40.00%7.00K
-98.58%3.00K
-71.43%8.00K
-76.19%5.00K
-76.19%5.00K
--211.00K
--28.00K
--21.00K
--21.00K
Operating profit
13.86%-3.49M
16.50%-3.21M
15.04%-3.71M
54.02%-3.77M
55.27%-4.05M
55.47%-3.85M
47.49%-4.37M
-31.04%-8.20M
-70.09%-9.05M
-72.01%-8.64M
-187.69%-8.32M
-127.17%-6.25M
-213.13%-5.32M
-125.49%-5.02M
-136.00%-2.89M
-150.05%-2.75M
0.29%-1.70M
3.72%-2.23M
83.15%-1.23M
75.74%-1.10M
68.60%-1.70M
---2.31M
---7.27M
---4.54M
---5.43M
Net non-operating interest income (expenses)
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
----
---3.35M
----
----
--0.00
Income before tax
14.09%-3.32M
13.29%-2.96M
15.79%-3.48M
54.25%-3.63M
55.70%-3.87M
58.64%-3.42M
48.81%-4.14M
-17.85%-7.94M
-71.08%-8.73M
-64.06%-8.26M
-172.24%-8.08M
-143.10%-6.73M
-199.53%-5.10M
-134.89%-5.04M
-142.48%-2.97M
-156.24%-2.77M
-0.53%-1.70M
61.74%-2.14M
82.92%-1.22M
75.65%-1.08M
82.90%-1.69M
---5.60M
---7.17M
---4.44M
---9.91M
Income tax
----
--0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
---55.00K
106.25%34.00K
--21.00K
--10.00K
--0.00
---544.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
14.09%-3.32M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.10M
-134.89%-5.04M
-142.48%-2.97M
-156.24%-2.77M
-0.53%-1.70M
61.74%-2.14M
82.92%-1.22M
75.65%-1.08M
82.90%-1.69M
---5.60M
---7.17M
---4.44M
---9.91M
Net income from continuous operations
14.09%-3.32M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.10M
-134.89%-5.04M
-142.48%-2.97M
-156.24%-2.77M
-0.53%-1.70M
61.74%-2.14M
82.92%-1.22M
75.65%-1.08M
82.90%-1.69M
---5.60M
---7.17M
---4.44M
---9.91M
Net income attributable to controlling interests
14.09%-3.32M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.10M
-134.89%-5.04M
-142.48%-2.97M
-156.24%-2.77M
-0.53%-1.70M
61.74%-2.14M
82.92%-1.22M
75.65%-1.08M
82.90%-1.69M
---5.60M
---7.17M
---4.44M
---9.91M
Net income attributable to common shareholders
14.09%-3.32M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.10M
-134.89%-5.04M
-142.48%-2.97M
-156.24%-2.77M
-0.53%-1.70M
61.74%-2.14M
82.92%-1.22M
75.65%-1.08M
82.90%-1.69M
---5.60M
---7.17M
---4.44M
---9.91M
Basic earnings per share
46.51%-0.01
56.14%-0.01
42.47%-0.01
97.79%-0.01
97.85%-0.01
97.77%-0.01
96.95%-0.02
-32.51%-0.58
-76.99%-0.63
-77.86%-0.59
-171.27%-0.57
-111.79%-0.43
-105.89%-0.36
64.28%-0.33
-142.46%-0.21
-53.78%-0.20
16.77%-0.17
61.71%-0.92
97.22%-0.09
93.04%-0.13
96.53%-0.21
---2.41
---3.09
---1.91
---6.02
Diluted earnings per share
46.51%-0.01
56.14%-0.01
42.47%-0.01
97.79%-0.01
97.85%-0.01
97.77%-0.01
96.95%-0.02
-32.51%-0.58
-76.99%-0.63
-77.86%-0.59
-171.27%-0.57
-111.79%-0.43
-105.89%-0.36
64.28%-0.33
-142.46%-0.21
-53.78%-0.20
16.77%-0.17
61.71%-0.92
97.22%-0.09
93.04%-0.13
96.53%-0.21
---2.41
---3.09
---1.91
---6.02
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
